Compugen Ltd. (NASDAQ: CGEN), a therapeutic discovery and development company, today announced that the United States Patent and Trademark Office ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE